Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database.

Seer Database ◽

Abstract P5-15-01: Breast cancer specific survival in 38,568 patients with node negative hormone receptor positive invasive breast cancer and oncotype DX recurrence score results in the SEER database

10.1158/1538-7445.sabcs15-p5-15-01 ◽

2016 ◽

Cited By ~ 12

Author(s):

S Shak ◽

VI Petkov ◽

DP Miller ◽

N Howlader ◽

N Gliner ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Seer Database ◽

Node Negative ◽

Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4162-3 ◽

2017 ◽

Vol 163 (2) ◽

pp. 303-310 ◽

Cited By ~ 39

Author(s):

Megan C. Roberts ◽

Dave P. Miller ◽

Steven Shak ◽

Valentina I. Petkov

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Invasive Breast Cancer ◽

Recurrence Score ◽

Seer Database ◽

Lymph Node Positive ◽

Breast cancer-specific survival in >4,600 patients with lymph node-positive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene recurrence score® (RS) results in the SEER registries

Annals of Oncology ◽

10.1093/annonc/mdw364.07 ◽

2016 ◽

Vol 27 ◽

pp. vi45 ◽

Cited By ~ 2

Author(s):

D.P. Miller ◽

M. Roberts ◽

V.I. Petkov ◽

S. Shak ◽

N. Howlader ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Node Positive ◽

Lymph Node Positive

Breast cancer-specific survival in 6,768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries

The Breast ◽

10.1016/s0960-9776(17)30311-9 ◽

2017 ◽

Vol 32 ◽

pp. S97-S98

Author(s):

S. Shak ◽

M. Roberts ◽

V.I. Petkov ◽

D.P. Miller ◽

N. Howlader ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Hormone Receptor Positive

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.00667 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 2

Author(s):

Mi Jeong Kwon ◽

Jeong Eon Lee ◽

Joon Jeong ◽

Sang Uk Woo ◽

Jinil Han ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Risk Classification ◽

Oncotype Dx ◽

Asian Women ◽

146P Prognostic impact of HER2-low expression according to the oncotype Dx recurrence score in hormone receptor-positive early breast cancer

Annals of Oncology ◽

10.1016/j.annonc.2021.08.427 ◽

2021 ◽

Vol 32 ◽

pp. S424

Author(s):

R. Mutai ◽

T. Barkan ◽

A. Moore ◽

M. Sarfaty ◽

S. Stemmer ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Prognostic Impact ◽

Oncotype Dx Recurrence Score ◽

Low Expression

A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor‒Positive, Human Epidermal Growth Factor 2 (HER2)‒Negative Breast Cancer

Cancer Research and Treatment ◽

10.4143/crt.2018.357 ◽

2019 ◽

Vol 51 (3) ◽

pp. 1073-1085 ◽

Cited By ~ 5

Author(s):

Sae Byul Lee ◽

Junetae Kim ◽

Guiyun Sohn ◽

Jisun Kim ◽

Il Yong Chung ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Human Epidermal Growth Factor ◽

Epidermal Growth ◽

Abstract P5-13-02: Neoadjuvant aromatase inhibitor therapy plus the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and an oncotype Dx recurrence score (≤25)

10.1158/1538-7445.sabcs19-p5-13-02 ◽

2020 ◽

Author(s):

Maysa M Abu-Khalaf ◽

Kimberly Aderhold ◽

Michal Marczyk ◽

Gina Chung ◽

Erin Hofstatter ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Mtor Inhibitor ◽

Recurrence Score ◽

Oncotype Dx ◽

Aromatase Inhibitor Therapy ◽

88. Validity of Oncotype Dx recurrence score in predicting recurrence in hormone receptor positive and node negative early breast cancer patients

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2016.06.094 ◽

2016 ◽

Vol 42 (9) ◽

pp. S103

Author(s):

A. Munir ◽

S. Udyashankar ◽

D. Thomas ◽

G. Dazeley ◽

A. Huws ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Breast Cancer Patients ◽

Node Negative ◽

Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come

Annals of Surgical Oncology ◽

10.1245/s10434-019-07240-y ◽

2019 ◽

Vol 26 (5) ◽

pp. 1173-1175 ◽

Cited By ~ 4

Author(s):

Elizabeth A. Mittendorf ◽

Tari A. King

Keyword(s):

Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Positive ◽